Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Other Accumulated Expenses (2016 - 2017)

Historic Other Accumulated Expenses for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to $963000.0.

  • Eledon Pharmaceuticals' Other Accumulated Expenses rose 74473.68% to $963000.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $963000.0, marking a year-over-year increase of 74473.68%. This contributed to the annual value of $12000.0 for FY2016, which is 9281.44% down from last year.
  • According to the latest figures from Q3 2017, Eledon Pharmaceuticals' Other Accumulated Expenses is $963000.0, which was up 74473.68% from $1.3 million recorded in Q2 2017.
  • In the past 5 years, Eledon Pharmaceuticals' Other Accumulated Expenses ranged from a high of $1.3 million in Q2 2017 and a low of $12000.0 during Q4 2016
  • Moreover, its 5-year median value for Other Accumulated Expenses was $129000.0 (2015), whereas its average is $263428.6.
  • In the last 5 years, Eledon Pharmaceuticals' Other Accumulated Expenses plummeted by 9281.44% in 2016 and then surged by 196349.21% in 2017.
  • Over the past 5 years, Eledon Pharmaceuticals' Other Accumulated Expenses (Quarter) stood at $60000.0 in 2013, then skyrocketed by 175.0% to $165000.0 in 2014, then grew by 1.21% to $167000.0 in 2015, then crashed by 92.81% to $12000.0 in 2016, then soared by 7925.0% to $963000.0 in 2017.
  • Its Other Accumulated Expenses was $963000.0 in Q3 2017, compared to $1.3 million in Q2 2017 and $229000.0 in Q1 2017.